Diabetologia

, Volume 33, Issue 2, pp 105–111 | Cite as

Examination of islets in the pancreas biopsy specimens from newly diagnosed Type 1 (insulin-dependent) diabetic patients

  • T. Hanafusa
  • A. Miyazaki
  • J. Miyagawa
  • S. Tamura
  • M. Inada
  • K. Yamada
  • Y. Shinji
  • H. Katsura
  • K. Yamagata
  • N. Itoh
  • H. Asakawa
  • C. Nakagawa
  • A. Otsuka
  • S. Kawata
  • N. Kono
  • S. Tarui
Originals

Summary

We attempted to examine the immunopathological change of the pancreatic islets of newly diagnosed Type 1 (insulin-dependent) diabetic patients and thereby to obtain useful information for the therapy of the patients. For this purpose, pancreas biopsy under laparoscopy was performed 2–4 months after the onset of Type 1 diabetes in seven newly diagnosed patients. All biopsies were performed safely without any complications. Immunohistochemical examination of the biopsy specimens revealed a marked decrease of insulin-containing cells, preservation of glucagon-containing cells, and various degrees of expression of MHC class I and class II antigens in islet cells and in endothelial cells within and around the islets. Signs of active autoimmune phenomena, e. g. lymphocytic infiltration or immunoglobulin deposition in islets, were not detected in any of these patients by light microscopical evaluation. We conclude that pancreas biopsy under laparoscopy has shown various immunological changes in the islets of newly diagnosed Type 1 diabetic patients. Pancreas biopsy, however, may not be suitable under the present protocol for the selection of patients for immunotherapy because of problems including sampling errors.

Key words

Type 1 (insulin-dependent) diabetes mellitus pathology pathogenesis diagnosis pancreas biopsy laparoscopy immunohistochemistry MHC class I antigen MHC class II antigen immunotherapy 

References

  1. 1.
    Eisenbarth GS (1986) Type I diabetes mellitus, a chronic autoimmune disease. N Engl J Med 314: 1360–1368PubMedGoogle Scholar
  2. 2.
    Bottazzo GF (1984) β-cell damage in diabetic-insulitis: are we approaching a solution? Diabetologia 26: 241–249CrossRefPubMedGoogle Scholar
  3. 3.
    Gepts W (1965) Pathological anatomy of the pancreas in juvenile diabetes. Diabetes 14: 619–633PubMedGoogle Scholar
  4. 4.
    Junker K, Egeberg J, Kromann H, Nerup J (1977) An autopsy study of the islets of Langerhans in acute-onset juvenile diabetes mellitus. Acta Pathol Microbiol Scand Sect A 85: 699–706Google Scholar
  5. 5.
    Doniach I, Morgan AG (1973) Islets of Langerhans in juvenile diabetes mellitus. Clin Endocrinol 2: 233–248Google Scholar
  6. 6.
    Foulis AK, Liddle CN, Farquharson MA, Richmond JA, Weir RS (1986) The histopathology of the pancreas in Type 1 (insulin-dependent) diabetes mellitus: a 25-year review of deaths in patients under 20 years of age in the United Kingdom. Diabetologia 29: 267–274PubMedGoogle Scholar
  7. 7.
    Bottazzo GF, Dean BM, McNally JM, MacKay EH, Swift PGF, Gamble DR (1985) In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis. N Engl J Med 313: 353–360PubMedGoogle Scholar
  8. 8.
    Meyer-Burg J (1972) The inspection, palpation and biopsy for the pancreas. Endoscopy 4: 99–101Google Scholar
  9. 9.
    Ishida H (1983) Peritoneoscopy and pancreas biopsy in the diagnosis of pancreatic diseases. Gastrointest Endosc 29: 211–218PubMedGoogle Scholar
  10. 10.
    Foulis AK, Farquharson MA (1986) Aberrant expression of HLA-DR antigens by insulin-containing beta-cells in recentonset Type I diabetes mellitus. Diabetes 35: 1215–1224PubMedGoogle Scholar
  11. 11.
    Foulis AK, Farquharson MA, Hardman R (1987) Aberrant expression of Class II major histocompatibility complex molecules by B cells and hyperexpression of Class I major histocompatibility complex molecules by insulin containing islets in Type 1 (insulin-dependent) diabetes mellitus. Diabetologia 30: 333–343PubMedGoogle Scholar
  12. 12.
    Bougneres PF, Carel JC, Castano L, Boitard C, Gardin JP, Landais P, Hors J, Mihatsch MJ, Pillard M, Chaussain JL, Bach JF (1988) Factors associated with early remission of Type I diabetes in children treated with cyclosporine. N Engl J Med 318: 663–670PubMedGoogle Scholar
  13. 13.
    Bottazzo GF, Pujol-Borrell R, Hanafusa T, Feldmann M (1983) Role of aberrant HLA-DR expression and antigen presentation in the induction of endocrine autoimmunity. Lancet II: 1115–1118CrossRefGoogle Scholar
  14. 14.
    Hanafusa T, Pujol-Borrell R, Chiovato L, Russell RCG, Doniach D, Bottazzo GF (1983) Aberrant expression of HLA-DR antigen on thyrocytes in Graves' disease: relevance for autoimmunity. Lancet II: 1111–1115CrossRefGoogle Scholar
  15. 15.
    Jenson AB, Rosenberg HS (1984) Multiple viruses in diabetes mellitus. Prog Med Virol 29: 197–217PubMedGoogle Scholar

Copyright information

© Springer-Verlag 1990

Authors and Affiliations

  • T. Hanafusa
    • 1
  • A. Miyazaki
    • 1
  • J. Miyagawa
    • 1
  • S. Tamura
    • 1
  • M. Inada
    • 1
  • K. Yamada
    • 2
  • Y. Shinji
    • 3
  • H. Katsura
    • 1
  • K. Yamagata
    • 1
  • N. Itoh
    • 1
  • H. Asakawa
    • 1
  • C. Nakagawa
    • 1
  • A. Otsuka
    • 1
  • S. Kawata
    • 1
  • N. Kono
    • 1
  • S. Tarui
    • 1
  1. 1.The Second Department of Internal MedicineOsaka University Medical SchoolOsaka
  2. 2.Department of Medicine, Division of Endocrinology and MetabolismKurume University School of MedicineKurume
  3. 3.Nishinomiya Prefectural HospitalHyogoJapan

Personalised recommendations